Abstract:<section class="article-section__content"><h3 class="article-section__sub-title section1"> Background</h3><p>Accurate and noninvasive detection of isocitrate dehydrogenase (IDH, including IDH1 and IDH2) status is clinically meaningful for molecular stratification of glioma, but remains challenging.</p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Purpose</h3><p>To establish a model for classifying IDH status in gliomas based on multiparametric MRI.</p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Study Type</h3><p>Retrospective, radiomics.</p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Population</h3><p>In all, 105 consecutive cases of grade II–IV glioma with 50 IDH1 or IDH2 mutant (IDHm) and 55 IDH wildtype (IDHw) were separated into a training cohort (<i>n =</i> 73) and a test cohort (<i>n =</i> 32). </p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Field Strength/Sequence</h3><p>Contrast‐enhanced T<sub>1</sub>‐weighted (CE‐T<sub>1</sub>W), T<sub>2</sub>‐weighted (T<sub>2</sub>W), and arterial spin labeling (ASL) images were acquired at 3.0T. </p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Assessment</h3><p>Two doctors manually labeled the volume of interest (VOI) on CE‐T<sub>1</sub>W, then T<sub>2</sub>W and ASL were coregistered to CE‐T<sub>1</sub>W. A total of 851 radiomics features were extracted on each VOI of three sequences. From the training cohort, all radiomics features with age and gender were processed by the Mann–Whitney <i>U</i>‐test, Pearson test, and least absolute shrinkage and selection operator to obtain optimal feature groups to train support vector machine models. The accuracy and area under curve (AUC) of all models for classifying the IDH status were calculated on the test cohort. Two subtasks were performed to verify the efficiency of texture features and the Pearson test in IDH status classification, respectively. </p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Statistical Tests</h3><p>The permutation test with Bonferroni correction; chi‐square test.</p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Results</h3><p>The accuracy and AUC of the classifier, which combines the features of all three sequences, achieved 0.823 and 0.770 (<i>P</i> < 0.05), respectively. The best model established by texture features only had an AUC of 0.819 and an accuracy of 0.761. The best model established without the Pearson test got an AUC of 0.747 and an accuracy of 0.719. </p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Data Conclusion</h3><p>IDH genotypes of glioma can be identified by radiomics features from multiparameter MRI. The Pearson test improved the performance of the IDH classification models.</p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Level of Evidence</h3><p>4</p></section><section class="article-section__content"><h3 class="article-section__sub-title section1"> Technical Efficacy Stage</h3><p>1</p></section>

IDH mutation status is associated with a distinct hypoxia/angiogenesis transcriptome signature which is non-invasively predictable with rCBV imaging in human glioma

Predicting IDH mutation status as well as Ki-67 and p53 expression in high-grade gliomas using amide proton transfer-weighted and arterial spin labeling MRI

Noninvasive Idh1 Mutation Estimation Based on A Quantitative Radiomics Approach for Grade Ii Glioma

IDH-mutation Status is Associated with Distinct Vascular Gene Expression Signatures in Lower Grade Gliomas.

Non-Invasive Prediction of IDH Mutation in Patients with Glioma WHO II/III/IV Based on F-18-FET PET-Guided In Vivo 1H-Magnetic Resonance Spectroscopy and Machine Learning

Predicting Isocitrate Dehydrogenase ( IDH) Mutation Status in Gliomas Using Multiparameter MRI Radiomics Features

IDH mutation-specific radiomic signature in lower-grade gliomas.

Qualitative and Quantitative MRI Analysis in IDH1 Genotype Prediction of Lower-Grade Gliomas: A Machine Learning Approach.

Path-39. Ai-Based Identification Of Glioma Idh Mutational Status From H&E-Stained Whole Slide Images

Visualization of tumor heterogeneity and prediction of isocitrate dehydrogenase mutation status for human gliomas using multiparametric physiologic and metabolic MRI

Predictive Role of the Apparent Diffusion Coefficient and MRI Morphologic Features on IDH Status in Patients With Diffuse Glioma: A Retrospective Cross-Sectional Study

Multiregional Radiomics Profiling from Multiparametric MRI: Identifying an Imaging Predictor of IDH1 Mutation Status in Glioblastoma

Machine Learning-Based Prediction of Glioma IDH Gene Mutation Status Using Physio-Metabolic MRI of Oxygen Metabolism and Neovascularization (A Bicenter Study)

DSC-MRI derived relative CBV maps synthesized from IVIM-MRI data:Application in glioma IDH mutation status identification

Using AI-Based Evolutionary Algorithms to Elucidate Adult Brain Tumor (Glioma) Etiology Associated with IDH1 for Therapeutic Target Identification

Predicting IDH Mutation Status in Low-Grade Gliomas Based on Optimal Radiomic Features Combined with Multi-Sequence Magnetic Resonance Imaging

Insight into deep learning for glioma IDH medical image analysis: A systematic review

Biological underpinnings of radiomic magnetic resonance imaging phenotypes for risk stratification in IDH wild-type glioblastoma

Multimodel Habitats Constructed by Perfusion And/or Diffusion MRI Predict Isocitrate Dehydrogenase Mutation Status and Prognosis in High-Grade Gliomas.

Completely non-invasive prediction of IDH mutation status based on preoperative native CT images

Isocitrate dehydrogenase1 mutation reduces the pericyte coverage of microvessels in astrocytic tumours